The Annual Clinical Trials Roundup: 2024 Edition

By Heidi Chen Associate Director, Research & Commercial Services

Clinical trials bounced back in 2023 from their decline a year earlier despite continued geopolitical, regulatory, and pricing pressures. The 9.4% increase in 2023 is a notable achievement, surpassing the average total growth of 7.8% seen during 2017–23. This report explores top disease areas, clinical trial activity, and a ranking of the top 10 industry trial sponsors. It also covers the still lingering effects of the COVID-19 pandemic, and how it served as a catalyst to highlight critical issues of traditional clinical trial methodologies.